# Genomic Valley Biotech Ltd (GVBL)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹25.4
Day Change: +0.08%
52W High: ₹55.37
52W Low: ₹20.1
Market Cap: ₹8 Cr

## Valuation
P/E: 0
P/B: 2.1
EPS: ₹-0.11
Book Value: ₹12.64
Dividend Yield: 0%

## Returns
1Y Return: -57.86%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Genomic Valley Biotech Ltd is a Biotechnology company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Genomic Valley Biotech Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement: Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation, 2011
- BSE Filing: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-21T04:15:19.838Z
Price History Updated: 2026-05-21T04:15:20.461Z
Latest Price History Date: 2026-05-21
Technicals Updated: 2026-05-21T04:15:20.461Z
Quant Updated: 2026-05-21T04:15:20.461Z
Sentiment Updated: 2026-05-21T04:15:20.461Z
Financials Status: current
Financials Updated: 2026-05-18T16:30:02.025Z
Financials Last Attempt: 2026-05-18T16:30:02.025Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2023)
Revenue: ₹3 Cr
Operating Profit: ₹1 Cr (OPM 32.09%)
Net Profit: ₹1 Cr
Tax: ₹0 Cr

## Balance Sheet (FY 2022)
Total Assets: ₹4 Cr
Total Liabilities: ₹1 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/gvbl
Disclaimer: For research and education only. Not investment advice.